Last reviewed · How we verify

NCT04282317

Magnetic Resonance Imaging of the Brain and Stomach in Healthy Volunteers and Gastroparesis

Active, enrolled NA Last updated 12 April 2024
What this trial tests

NA trial testing MRI scan in Gastroparesis in 31 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
1 August 2019
Primary endpoint
31 December 2025
31 December 2026

Quick facts

Lead sponsorIndiana University School of Medicine
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposehealth services research
Enrollment31
Start date1 August 2019
Primary completion31 December 2025
Estimated completion31 December 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Indiana University School of Medicine

Who can join

Adults 18 to 65, any sex, with Gastroparesis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study is to lay the groundwork for non invasive imaging of the GI tract and the brain gut interaction

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of MRI scan

Trials testing the same drug.

Other recruiting trials for Gastroparesis

Currently open trials in the same condition.

Other Indiana University School of Medicine trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04282317.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing